Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2019 - 06/30/2019

Lobbyist name	Paul Barry
Business name	Boston Scientific Corp.
Address	1455 Pennsylvania Ave, NW Suite 925
City, state, zip code	Washington, DC 20004
Country	US
Agent type	Both
Phone	202-637-8020

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Boston Scientific Corp.

Total amount paid by client; lobbyist is unable to report compensation at activity level: $1,936.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1451	An Act adopting the federal Uniform Trade Secret Act	Oppose	$0.00	N/A
Senate Bill	1081	An Act ensuring that employees of companies that receive large tax breaks are paid a prevailing wage	Neutral	$0.00	N/A
Senate Bill	3	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	1295	An Act to reduce healthcare costs by promoting non-biased prescriber education	Neutral	$0.00	N/A
House Bill	218	An Act relative to the digital right to repair	Oppose	$0.00	N/A
Senate Bill	519	An Act for a competitive economy through safer alternatives to toxic chemicals	Support	$0.00	N/A
Senate Bill	1721	An Act relative to economic development tax credits	Oppose	$0.00	N/A
House Bill	828	An Act to reform the Toxic Use Reduction Act	Neutral	$0.00	N/A
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	N/A
House Bill	810	An Act relative to extender producer responsibility	Neutral	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Neutral	$0.00	N/A
Senate Bill	149	An Act relative to the disclosure of toxic chemicals in children?s products	Oppose	$0.00	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	N/A
House Bill	1	making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	518	An Act relative to information technology producer responsibility	Support	$0.00	N/A
Senate Bill	1702	An Act relative to excessive executive compensation	Oppose	$0.00	N/A
House Bill	797	An Act to require producer responsibility for collection, reuse and recycling of discarded electronic products	Neutral	$0.00	N/A
Senate Bill	653	An Act relative to prescription drug pricing	Neutral	$0.00	N/A
House Bill	3801	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	1117	An Act relative to clarifying legislative intent regarding the non-competition law	Support	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Neutral	$0.00	N/A
Senate Bill	715	An Act relative to pharmaceutical price transparency and cost sharing	Neutral	$0.00	N/A
House Bill	1013	An Act relative to pharmaceutical gag clauses	Neutral	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Neutral	$0.00	N/A
Senate Bill	464	An Act relative to environmental justice and toxics reduction in the Commonwealth	Neutral	$0.00	N/A
Senate Bill	1651	An Act to promote sustainable economic development throughout Massachusetts	Neutral	$0.00	N/A
Senate Bill	107	An Act relative to the digital right to repair	Neutral	$0.00	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
Senate Bill	1083	An Act relative to banning noncompetition agreements in the Commonwealth	Oppose	$0.00	N/A
House Bill	248	An Act relative to the disclosure of toxic chemicals in children?s products	Neutral	$0.00	N/A
Senate Bill	601	An Act to reduce the cost of pharmacy benefits	Neutral	$0.00	N/A
Senate Bill	1770	An Act relative to the creation of a super research and development tax credit	Neutral	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Neutral	$0.00	N/A
Senate Bill	652	An Act relative to pharmaceutical gag clauses	Neutral	$0.00	N/A
Senate Bill	2235	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.

Close this page

Connect with Us